IDEAS home Printed from https://ideas.repec.org/r/bpj/bejeap/v7y2007i1n23.html
   My bibliography  Save this item

Vaccination Externalities

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Rikard Forslid & Mathias Herzing, 2015. "On the Optimal Production Capacity for Influenza Vaccine," Health Economics, John Wiley & Sons, Ltd., vol. 24(6), pages 726-741, June.
  2. Andrea Galeotti & Brian W. Rogers, 2013. "Strategic Immunization and Group Structure," American Economic Journal: Microeconomics, American Economic Association, vol. 5(2), pages 1-32, May.
  3. Toxvaerd, Flavio & Rowthorn, Robert, 2022. "On the management of population immunity," Journal of Economic Theory, Elsevier, vol. 204(C).
  4. Corey White, 2021. "Measuring Social and Externality Benefits of Influenza Vaccination," Journal of Human Resources, University of Wisconsin Press, vol. 56(3), pages 749-785.
  5. Gunjan Kumari & Oindrila Dey, 2024. "Can redistribution of vaccine improve global welfare? Lessons from COVID-19," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 25(7), pages 1217-1238, September.
  6. Xinyan Shi, 2013. "Information disclosure and vaccination externalities," International Journal of Economic Theory, The International Society for Economic Theory, vol. 9(3), pages 229-243, September.
  7. Daoping Wang & Ottar N. Bjørnstad & Tianyang Lei & Yida Sun & Jingwen Huo & Qi Hao & Zhao Zeng & Shupeng Zhu & Stéphane Hallegatte & Ruiyun Li & Dabo Guan & Nils C. Stenseth, 2023. "Supply chains create global benefits from improved vaccine accessibility," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
  8. Stankov, Petar, 2024. "Will voters polarize over pandemic restrictions? Theory and evidence from COVID-19," Economic Modelling, Elsevier, vol. 136(C).
  9. Westerink-Duijzer, L.E. & van Jaarsveld, W.L. & Wallinga, J. & Dekker, R., 2015. "Dose-optimal vaccine allocation over multiple populations," Econometric Institute Research Papers EI2015-29, Erasmus University Rotterdam, Erasmus School of Economics (ESE), Econometric Institute.
  10. Andrew Souther & Myong-Hun Chang & Troy Tassier, 2023. "It’s worth a shot: urban density, endogenous vaccination decisions, and dynamics of infectious disease," Journal of Economic Interaction and Coordination, Springer;Society for Economic Science with Heterogeneous Interacting Agents, vol. 18(1), pages 163-189, January.
  11. Goodkin-Gold, Matthew & Kremer, Michael & Snyder, Christopher M. & Williams, Heidi, 2022. "Optimal vaccine subsidies for endemic diseases," International Journal of Industrial Organization, Elsevier, vol. 84(C).
  12. Troy Tassier & Philip Polgreen & Alberto Segre, 2017. "Network position and health care worker infections," Journal of Economic Interaction and Coordination, Springer;Society for Economic Science with Heterogeneous Interacting Agents, vol. 12(2), pages 277-307, July.
  13. Fenichel, Eli P., 2013. "Economic considerations for social distancing and behavioral based policies during an epidemic," Journal of Health Economics, Elsevier, vol. 32(2), pages 440-451.
  14. Chanel, Olivier & Luchini, Stéphane & Massoni, Sébastien & Vergnaud, Jean-Christophe, 2011. "Impact of information on intentions to vaccinate in a potential epidemic: Swine-origin Influenza A (H1N1)," Social Science & Medicine, Elsevier, vol. 72(2), pages 142-148, January.
  15. Ze Chen & Bingzheng Chen & Yu Mao, 2024. "Fence off Black Swans: The Economics of Insurance for Vaccine Injury," Oxford Bulletin of Economics and Statistics, Department of Economics, University of Oxford, vol. 86(5), pages 995-1025, October.
  16. Charles F. Manski, 2014. "Vaccine Approvals and Mandates Under Uncertainty: Some Simple Analytics," NBER Working Papers 20432, National Bureau of Economic Research, Inc.
  17. Ibuka, Yoko & Bessho, Shun-ichiro, 2015. "Subsidies for influenza vaccination, vaccination rates, and health outcomes among the elderly in Japan," Japan and the World Economy, Elsevier, vol. 36(C), pages 56-66.
  18. repec:esx:essedp:707 is not listed on IDEAS
  19. Toxvaerd, F. & Rowthorn, R., 2020. "On the Management of Population Immunity," Cambridge Working Papers in Economics 2080, Faculty of Economics, University of Cambridge.
  20. Toxvaerd, Flavio, 2010. "Infection, Acquired Immunity and Externalities in Treatment," CEPR Discussion Papers 8111, C.E.P.R. Discussion Papers.
  21. Troy Tassier & Philip Polgreen & Alberto Segre, 2015. "Vaccination Games with Peer Effects in a Heterogeneous Hospital Worker Population," Administrative Sciences, MDPI, vol. 5(1), pages 1-25, January.
  22. Donald T. Lauria & Brian Maskery & Christine Poulos & Dale Whittington, 2008. "An Optimisation Model for Use of the Vi Polysaccharide Vaccine to Prevent Typhoid in Developing Countries," Global Development Institute Working Paper Series 1808, GDI, The University of Manchester.
  23. repec:esx:essedp:716 is not listed on IDEAS
  24. Telalagic, S., 2012. "Optimal Treatment of an SIS Disease with Two Strains," Cambridge Working Papers in Economics 1229, Faculty of Economics, University of Cambridge.
  25. Toxvaerd, Flavio, 2010. "Recurrent Infection and Externalities in Prevention," CEPR Discussion Papers 8112, C.E.P.R. Discussion Papers.
  26. Joseph Cook & Marc Jeuland & Brian Maskery & Donald Lauria & Dipika Sur & John Clemens & Dale Whittington, 2009. "Using private demand studies to calculate socially optimal vaccine subsidies in developing countries," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 28(1), pages 6-28.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.